产品特点
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Floxabactin 150 mg tablets for dogs
Floxabactin Vet. (DK)
Floxabactin Vet. 150 mg tablets for dogs (SE, NO, FI)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Enrofloxacin
150.0 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
A white to slightly yellow, round, convex snap-tab tablet for oral administration to
dogs .
The tablet can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of lower urinary tract infections (associated or not with prostatitis) and upper
urinary tract infections caused by Escherichia coli or Proteus mirabilis.
Treatment of superficial and deep pyoderma.
4.3
CONTRAINDICATIONS
Do not use in young or growing dogs (aged less than 12 months (small breed) or less than 18
months (large breed)) as the product may cause epiphyseal cartilage alterations in growing
puppies.
Do not use in dogs having seizure disorders, since enrofloxacin may cause CNS stimulation.
Do not use in dogs with known hypersensitivity to fluoroquinolones or to any of the
excipients of the product.
Do not use in case of resistance to quinolones, as there exists almost complete cross resistance
to
other quinolones and complete cross resistance to other fluoroquinolones.
Do not use with tetracyclines, phenicol
阅读完整的文件